Vascular Access Outcomes in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Suzanne L Laboyrie Maria K Svensson Sabine H JosemansBirgitta SigvantJoris I Rotmans Gunilla Welander

Published in: Kidney360 (2024)

These findings suggest that AVF/AVG patency remains comparable in ESKD patients with or without ADPKD, and vascular access monitoring and treatment strategies for ADPKD patients should align with those for individuals with other ESKD causes.

Keyphrases

polycystic kidney disease
end stage renal disease
newly diagnosed
prognostic factors
metabolic syndrome
patient reported outcomes
skeletal muscle